Real-world effectiveness of omalizumab for severe allergic asthma treatment in Colombia

BACKGROUND: The allergic phenotype is responsible for more than 50% of severe asthma cases. In a stepwise approach, add-on treatments such as anti-IgE are used for severe allergic asthma (SAA). This study was aimed to describe the real-world effectiveness of omalizumab in adult and pediatric patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Torres-Duque, Carlos A., Ocampo-Gómez, Jaime, Castillo, Mauricio Morales, Cano-Rosales, Diana, Giraldo-Montoya, Ángela, Rodríguez, Freddy, Palacios-Ortega, Isabel, Durán-Silva, Mauricio, Reynales, Humberto, García, Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703713/
https://www.ncbi.nlm.nih.gov/pubmed/36437461
http://dx.doi.org/10.1186/s12890-022-02246-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703713/
https://www.ncbi.nlm.nih.gov/pubmed/36437461
http://dx.doi.org/10.1186/s12890-022-02246-x

Ejemplares similares